Showing results (61-70 of 108) with videos related to
Sort By:
Pageof 11
Biorxiv : the Preprint Server for Biology|October 21, 2021
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecovirusesPengfei Wang, Ryan G Casner, Manoj S Nair, et al.Cell Host & Microbe|April 22, 2020
VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgAManxue Jia, Rachel A Liberatore, Yicheng Guo, et al.Plos Pathogens|April 12, 2016
Targeted Isolation of Antibodies Directed against Major Sites of SIV Env VulnerabilityRosemarie D Mason, Hugh C Welles, Cameron Adams, et al.Plos Pathogens|May 25, 2016
Correction: Targeted Isolation of Antibodies Directed against Major Sites of SIV Env VulnerabilityRosemarie D Mason, Hugh C Welles, Cameron Adams, et al.Journal of Virology|August 28, 2020
Human Monoclonal Antibody Derived from Transchromosomic Cattle Neutralizes Multiple H1 Clades of Influenza A Virus by Recognizing a Novel Conformational Epitope in the Hemagglutinin Head DomainRongyuan Gao, Chithra C Sreenivasan, Zizhang Sheng, et al.NPJ Vaccines|October 25, 2024
Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolatesLaty G Thiam, Kirsty McHugh, Aboubacar Ba, et al.Medrxiv : the Preprint Server for Health Sciences|November 1, 2024
Genetic diversity in the Plasmodium falciparum next-generation blood stage vaccine candidate antigen PfCyRPA in SenegalAboubacar Ba, Laty Gaye Thiam, Mariama Nicole Pouye, et al.Nature|July 5, 2022
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5Qian Wang, Yicheng Guo, Sho Iketani, et al.Research Square|February 3, 2021
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody NeutralizationPengfei Wang, Lihong Liu, Sho Iketani, et al.Nature|March 8, 2021
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7Pengfei Wang, Manoj S Nair, Lihong Liu, et al.Pageof 11